BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35605655)

  • 1. The role of PICT1 in RPL11/Mdm2/p53 pathway-regulated inhibition of cell growth induced by topoisomerase IIα inhibitor against cervical cancer cell line.
    Rao Z; Shen J; Wang J; Zhang Z; Zhou J; Zhu J; Chen J; Chen W; Wang H
    Biochem Pharmacol; 2022 Jul; 201():115098. PubMed ID: 35605655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PICT1 is critical for regulating the Rps27a-Mdm2-p53 pathway by microtubule polymerization inhibitor against cervical cancer.
    Wang H; Zhao J; Yang J; Wan S; Fu Y; Wang X; Zhou T; Zhang Z; Shen J
    Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119084. PubMed ID: 34166715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of RPL11 in the enhancement of P53 stability by a podophyllum derivative, a topoisomerase II inhibitor.
    Wang H; Feng J; Zhou T; Wei L; Zhou J
    Cell Biol Int; 2018 Jan; 42(1):121-129. PubMed ID: 28949066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11.
    Sasaki M; Kawahara K; Nishio M; Mimori K; Kogo R; Hamada K; Itoh B; Wang J; Komatsu Y; Yang YR; Hikasa H; Horie Y; Yamashita T; Kamijo T; Zhang Y; Zhu Y; Prives C; Nakano T; Mak TW; Sasaki T; Maehama T; Mori M; Suzuki A
    Nat Med; 2011 Jul; 17(8):944-51. PubMed ID: 21804542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PICT1 regulates TP53 via RPL11 and is involved in gastric cancer progression.
    Uchi R; Kogo R; Kawahara K; Sudo T; Yokobori T; Eguchi H; Sugimachi K; Maehama T; Mori M; Suzuki A; Komune S; Mimori K
    Br J Cancer; 2013 Oct; 109(8):2199-206. PubMed ID: 24045667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-3F, a microtubule polymerization inhibitor enhances P53 stability through the change in localization of RPS27a.
    Wang H; Feng J; Zhou T; Wei L; Zhou J
    Int J Biochem Cell Biol; 2017 Nov; 92():53-62. PubMed ID: 28928040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells.
    Wang HT; Chen TY; Weng CW; Yang CH; Tang MS
    Oncotarget; 2016 Dec; 7(49):80450-80464. PubMed ID: 27741518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PICT-1 is a key nucleolar sensor in DNA damage response signaling that regulates apoptosis through the RPL11-MDM2-p53 pathway.
    Chen H; Han L; Tsai H; Wang Z; Wu Y; Duo Y; Cao W; Chen L; Tan Z; Xu N; Huang X; Zhuang J; Huang L
    Oncotarget; 2016 Dec; 7(50):83241-83257. PubMed ID: 27829214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway.
    Wang B; Gao J; Zhao Z; Zhong X; Cui H; Hou H; Zhang Y; Zheng J; Di J; Liu Y
    Mol Med; 2022 Sep; 28(1):109. PubMed ID: 36071402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribosomal protein L4 is a novel regulator of the MDM2-p53 loop.
    He X; Li Y; Dai MS; Sun XX
    Oncotarget; 2016 Mar; 7(13):16217-26. PubMed ID: 26908445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels.
    Goudarzi KM; Nistér M; Lindström MS
    Cancer Biol Ther; 2014; 15(11):1499-514. PubMed ID: 25482947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway and promotes tumorigenesis.
    Kayama K; Watanabe S; Takafuji T; Tsuji T; Hironaka K; Matsumoto M; Nakayama KI; Enari M; Kohno T; Shiraishi K; Kiyono T; Yoshida K; Sugimoto N; Fujita M
    EMBO Rep; 2017 Jan; 18(1):123-137. PubMed ID: 27856536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new PICTure of nucleolar stress.
    Suzuki A; Kogo R; Kawahara K; Sasaki M; Nishio M; Maehama T; Sasaki T; Mimori K; Mori M
    Cancer Sci; 2012 Apr; 103(4):632-7. PubMed ID: 22320853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition.
    Zhou X; Hao Q; Zhang Q; Liao JM; Ke JW; Liao P; Cao B; Lu H
    Cell Death Differ; 2015 May; 22(5):755-66. PubMed ID: 25301064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
    Liu K; Xue B; Bai G; Zhang W
    Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleolar Stress Response via Ribosomal Protein L11 Regulates Topoisomerase Inhibitor Sensitivity of P53-Intact Cancers.
    Ishihara Y; Nakamura K; Nakagawa S; Okamoto Y; Yamamoto M; Furukawa T; Kawahara K
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RPL34-AS1-induced RPL34 inhibits cervical cancer cell tumorigenesis via the MDM2-P53 pathway.
    Zhu Y; Ren C; Jiang D; Yang L; Chen Y; Li F; Wang B; Zhang Y
    Cancer Sci; 2021 May; 112(5):1811-1821. PubMed ID: 33675124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress.
    Zhou X; Hao Q; Liao J; Zhang Q; Lu H
    Oncogene; 2013 Jan; 32(3):388-96. PubMed ID: 22391559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribosomal protein RPL11 haploinsufficiency causes anemia in mice via activation of the RP-MDM2-p53 pathway.
    Franklin DA; Liu S; Jin A; Cui P; Guo Z; Arend KC; Moorman NJ; He S; Wang GG; Wan YY; Zhang Y
    J Biol Chem; 2023 Jan; 299(1):102739. PubMed ID: 36435197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
    Liu S; Tackmann NR; Yang J; Zhang Y
    Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.